|
| ID |
DDInter143 |
| Drug Type |
small molecule |
| Molecular Formula |
C29H34Cl2N6O3S2 |
| Molecular Weight |
649.668
|
| Description |
Avatrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a procedure.
|
| ATC Classification |
B02BX08
|
| IUPAC Name |
1-(3-Chloro-5-{[4-(4-Chlorothiophen-2-Yl)-5-(4-Cyclohexylpiperazin-1-Yl)-1,3-Thiazol-2-Yl]Carbamoyl}Pyridin-2-Yl)Piperidine-4-Ca |
| InChI |
Inchi=1S/C29H34Cl2N6O3S2/C30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/H14-18,21H,1-13H2,(H,39,40)(H,33,34,38) |
| InChI Key |
OFZJKCQENFPZBH-UHFFFAOYSA-N |
| Canonical SMILES |
OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|